CT colonography can screen for both colorectal cancer and osteoporosis reliably at minimal additional cost and time, according to a study at San Francisco VA Hospital.
CT colonography can screen for both colorectal cancer and osteoporosis reliably at minimal additional cost and time, according to a study at San Francisco VA Hospital.
Given the nature of CT colonography, radiologists may construct scans into 3D models of the spine, which can then be used to measure bone mineral density, according to lead author of the study Dr. Rizwan Aslam, an assistant clinical professor of radiology at the University of California, San Francisco. Radiologists can then use the information to determine the risk or presence of osteoporosis.
"We wanted to look at the ability of CT to not only screen for colon cancer but also allow identification of patients with osteoporosis, and we thought we could crack both of them with this test," Aslam said.
The retrospective study compared dual x-ray absorptiometry (DXA) scores with CT colonography results in 30 men and five women ranging in age from 54 to 79. All CT scans were performed on a 16-slice scanner.
Results showed excellent agreement between the DXA bone mineral density scores and the data obtained through the CT colonography study. The researchers found a correlation of 0.41 and 0.39 for the CT and DXA BMD readings per vertebral body level and 0.5 and 0.51 for the CT and DXA T-score per vertebral body. The ability to perform colonography and bone densitometry simultaneously could be especially valuable because colon cancer and osteoporosis both affect adults older than 50. Doubling up the exams also means avoiding radiation exposure from a second scan.
"Virtual colonoscopy can successfully evaluate patients for osteoporosis, and colonoscopy provides valuable information on osteoporosis risk with no additional radiation or cost," Aslam said.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.